| 24-Sep-2010 | S | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 24, 2010, has approved the proposal to sub-divide the nominal value of the equity shares of the Company from the nominal (face) value of Rs. 5 each to the nominal (face) value of Re. 1 each, subject to the approval of the Members of the Company.
Sun Pharmaceutical Industries Ltd has informed BSE that the members of the Company, by way of Postal Ballot , have passed the following resolutions, with requisite majority:
1. Ordinaiy Resolution for Sub-division of Equity shares of the Company from face value Rs. 5/- each to face value Re. 1 each and consequent alteration of the Memorandum of Association.
2. Special Resolution for Alteration of the Articles of Association consequent to the sub-division of the shares of the Company from face value Rs. 5/- each to face value Re. 1/- each.
(As Per BSE Announcement Website dated on 13.11.2010)
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed November 26, 2010 as the Record Date for the purpose of ascertaining the names of the shareholders who would be entitled to receive 5 (five) equity shares of the nominal face value of Re. 1 each for every 1 (one) equity of Rs. 5 each held by them.
(As Per BSE Announcement Website dated on 15.11.2010)
SUB. :- Sub Division of equity shares of Sun Pharmaceutical Industries Limited (Scrip Code 524715)
Trading Members of the Exchange are hereby informed that, Sun Pharmaceutical Industries Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Sun Pharmaceutical Industries Limited
(524715 & 624715)
RECORD DATE
26.11.2010
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUEE W.E.F.
25/11/2010 DR-169/2010- 2011
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 25/11/2010.
ii. ISIN No. INE 044 A01028 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 25/11/2010.
iii. The new ISIN Number for Re.1- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 16.11.2010) | 26-Nov-2010 | |
| 28-Oct-2002 | S | The Board of Directors of the company at its meeting held on 28/10/2002 has approved the following :-
The Split / sub division of the company's equity shares of Rs.10/- each into 2 equity shares of Rs.5/- each subject to the approval of Equity shareholders at the ensuing EGM of the company.
Sub-division of existing equity share from every one existing equity share of Rs. 10/- each into two equity shares of Rs. 5/- each.
REDUCED PAID-UP VALE : Rs. 5/-
REDUCED PAID-UP VALUE W.E.F. : 13.01.2003
(As Per BSE Notice Dated 06.01.2003) | 21-Jan-2003 | |
| 22-May-2024 | D | Board of Directors of the Company was held today i.e. May 22, 2024
Final dividend of Rs. 5/- (Rupees Five only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company. Final dividend, once approved by the shareholders, shall be to be paid within the prescribed timeline under the Companies Act, 2013. | 12-Jul-2024 | |
| 31-Jan-2024 | D | Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the following:
Declaration of Interim Dividend for the financial year 2023-24
An interim dividend of Rs. 8.5/- (Rupees Eight and fifty paisa only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2023-24 is declared. As intimated on January 15, 2024, the Record Date for entitlement of interim dividend for the financial year 2023-24 is February 09, 2024.
The interim dividend shall be paid on or before February 23, 2024. | 09-Feb-2024 | |
| 26-May-2023 | D | With reference to the intimation of Board meeting submitted on May 11, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. May 26, 2023 which commenced at 10:40 a.m. and ended at 02:35 p.m., wherein the Board has, inter-alia, Recommended Final Dividend for financial year 2022-23 Final dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re. l/- (Rupee One only) each of the Company is recommended subject to approval of the shareholders at the ensuing 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013. | 28-Jul-2023 | |
| 31-Jan-2023 | D | The Board has, inter-alia, Considered and approved declaration of Interim Dividend for the financial year 2022-23 An interim dividend of Rs. 7.50/- (Rupees seven and paise fifty only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2022-23. Further, as already intimated on January 16, 2023, the Record Date for entitlement of interim dividend for the financial year 2022-23 is February 08, 2023. The interim dividend shall be paid on or before February 20, 2023. | 08-Feb-2023 | |
| 30-May-2022 | D | Attached
Final dividend of Rs. 3.00 /- (Rupees Three only) per equity share of face value of Re.1/- each of the Company is recommended subject to the approval of the shareholders at the ensuing Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013. | 19-Aug-2022 | |
| 31-Jan-2022 | D | Declared interim dividend of Rs. 7/- (Rupees Seven Only) per equity share of Re. l/- each of the Company for the financial year ending on March 31, 2022. Refer letter attached | 09-Feb-2022 | |
| 27-May-2021 | D | Recommended payment of final dividend of Rs. 2/- (Rupees Two Only) per equity share of Re. l/-each of the Company for the year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or before about September 17, 2021. | 23-Aug-2021 | |
| 29-Jan-2021 | D | The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. 1/- each of the Company for the financial year ending on March 31, 2021. | 09-Feb-2021 | |
| 27-May-2020 | D | As per file attached | 19-Aug-2020 | |
| 06-Feb-2020 | D | As per letter attached
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed February 18, 2020 as the Record Date for the purpose of Payment of Interim Dividend.
The payment of the interim dividend would be made to the eligible shareholders on or before February 24, 2020.
(As Per BSE Announcement Dated on 07/02/2020) | 17-Feb-2020 | |
| 28-May-2019 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended payment of dividend of Rs. 2.75/- (Rupees Two and parse seventy five Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2019, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of August, 2019 or first week of September, 2019. | 20-Aug-2019 | |
| 25-May-2018 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2018, inter alia, has recommended payment of dividend of Rs. 2/- (Rupees Two Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
The dividend is expected to be paid on or about last week of September, 2018. | 17-Sep-2018 | |
| 26-May-2017 | D | The Board of Directors of the Company at its meeting held today
The Board of Directors of the Company at their meeting held today recommended payment of dividend of Rs. 3.5/- (Rupees Three and Fifty Paise Only) per equity share of Re.1/- each of the Company for the year ended March 31, 2017, subject to the approval of the members at the ensuing Annual General Meeting of the Company. | 18-Sep-2017 | |
| 30-May-2016 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has transacted the following:
1. Recommended payment of dividend of Re. 1/- (Rupee One Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2016, subject to the approval of the members at the ensuing Annual General Meeting of the Company.
The dividend will be paid on or about last week of September, 2016. | 08-Sep-2016 | |
| 11-Aug-2015 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2015, inter alia, has recommended payment of dividend of Rs. 3 (Rupees Three Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2015, subject to the approval of the members at the ensuing Annual General Meeting of the Company to be held in around end of October 2015. | 21-Oct-2015 | |
| 13-Aug-2014 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at their meeting held August 12, 2014 recorded approval of Scheme of Arrangement & Reconstruction between Sun Pharmaceutical Industries Ltd., and Sun Pharma Global FZE in the nature of demerger and transfer of the Specified Undertaking of Sun Pharma Global FZE to the Company with effect from the appointed date of May 01, 2013 as per the order of the Hon'ble High Court of Gujarat, at Ahmedabad at its hearing held on July 10, 2014 and accordingly after taking into effect of the above Scheme, approved the revised annual accounts for the year ended March 31, 2014.
The Board of Directors of the Company also recommended payment of dividend of Rs. 1.50 (Rupees One and Fifty paise) per equity share of Re.1/- each of the Company for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting of the Company. | 11-Sep-2014 | |
| 28-May-2013 | D | Sun Pharmaceutical Industries Ltd has informed BSE
that the Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has recommended payment of dividend of Rs. 5 (Rupees Five) per equity share of Re. 1/- each of the Company (pre bonus as recommended as below) for the year ended March 31, 2013 subject to the approval of the members at the ensuing Annual General Meeting of the Company.
Sun Pharmaceutical Industries Ltd has informed BSE that post-Bonus dividend i.e. dividend now payable to the equity shareholders for the accounting year ended March 31, 2013 will be @ Rs. 2.50/- per outstanding equity share of Re. 1 each.
(As per BSE Announcement Dated on 07.08.2013) | 19-Sep-2013 | |
| 29-May-2012 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on may 29, 2012, inter alia, has recommended payment of dividend of Rs.4.25 (Rupees Four and paise Twenty Five) per equity share of Re.1/- each of the Company for the year ended March 31, 2012 subject to the approval of the members at the ensuing Annual General Meeting of the Company. The dividend, if declared by the shareholders will be paid on or after about September 20, 2012.
Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 10, 2012, inter alia, have transacted the following :
The Board of Directors further declared the interim dividend of Rs. 4.25 per Share of Re. 1 each on Equity Shares of the Company for the year ended March 31, 2012 in lieu of the earlier proposed dividend of Rs. 4.25 per Share of Re. 1 each on Equity Shares of the Company for the year ended March 31, 2012 in view of the likely delay for the redrawing and audit of the revised accounts for the year ended March 31, 2012 and adoption of accounts by the members so as to give effect to the proposed rationalisation of the business of the Company with effect from March 31, 2012.
(AsPer BSE ANnouncement Website Dated on 10/08/2012) | 14-Aug-2012 | |
| 28-May-2011 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2011, inter alia, has recommended payment of dividend of Rs. 3.50 (Rupees Three and paise fifty) per equity share of Re. 1/- each of the Company for the year ended March 31, 2011 subject to the approval of the members at the ensuing Annual General Meeting of the Company. The dividend, if declared by the shareholders will be paid on or after about September 20, 2011. | 02-Sep-2011 | |
| 24-May-2010 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2010, inter alia, has recommended payment of dividend of Rs. 13.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2010 subject approval of the members. | 09-Sep-2010 | |
| 30-May-2009 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2009, inter alia, has recommended payment of dividend of Rs 13.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2009 subject to the approval of the members at the ensuing Annual General Meeting of the Company. | 21-Aug-2009 | |
| 30-May-2008 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2008, inter alia, has recommended payment of dividend @ 210% on the equity shares of the Company for the year ended March 31, 2008 subject to the approval of the members at the ensuing Annual General Meeting of the Company. | 25-Aug-2008 | |
| 12-Mar-2007 | D | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2007, has declared an interim dividend @ 6% p.a. on the outstanding 6% Cumulative Redeemable Preference Shares of Re 1/- each and @ 135% on equity shares of Rs 5/- each i.e. Rs 6.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2007.
Sun Pharmaceutical Industries Ltd has informed BSE that:
The Board of Directors had recommended that the interim dividend at the rate of 135% (Rs 6.75 per share) on the equity share capital and at the rate of 6% (Rs 0.06 per share) on the outstanding redeemable preference shares declared at its meeting held on March 10, 2007 and paid, be treated as final dividend for the financial year 2006-07.
(As Per BSE Announcement Website Dated on 18/05/2007) | 15-Mar-2007 | |
| 31-Oct-2005 | D | 75% Dividend | 19-Sep-2005 | |
| 19-Jul-2013 | B | SUB. :- Bonus issue of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715)
Trading Members of the Exchange are hereby informed that Sun Pharmaceutical Industries Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Sun Pharmaceutical Industries Ltd.
(424715, 524715, 624715)
RECORD DATE
30.07.2013
PURPOSE
Issue of 1 (ONE) Bonus equity share of Re. 1/- each for every 1 (ONE) equity share of Re. 1/- each held.
Ex-Bonus basis from Date & Sett. No.
29/07/2013 DR-086/2013-2014
Trading Members of the Exchange are requested to take note of it. | 30-Jul-2013 | 1:1 |
| 14-May-2004 | B | Members of the Exchange are hereby informed that, Sun Pharmaceuticals Ltd.has fixed the Record Date for the purpose of Bonus Issue. The transactions
in the equity shares of the company should be done on an ex-bonus basis with effect from the undermentioned date.
ONE Bonus share for every ONE existing Equity Share held in the company. | 29-May-2004 | 1:1 |
| 05-Sep-2002 | B | Four bonus 6% Cumulative Redeemable Preference shares of Re.1/- each for every one existing equity share held. | 10-Oct-2002 | 4:1 |
| 16-Nov-2024 | BC | Source:BSE Announcement PDF | 15-Nov-2024 | |
| 09-Oct-2024 | BC | SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Financial Results for the qu | 28-Oct-2024 | |
| 20-Aug-2024 | BC | Source:BSE Announcement PDF | 20-Aug-2024 | |
| 19-Jun-2024 | BC | AGM 05/08/2024
Intimation of 32nd Annual General Meeting and Connected Matters
(As Per BSE Announcement dated on 19.06.2024)
Intimation regarding Newspaper Publication for Notice of 32nd An | 05-Aug-2024 | |
| 15-Jul-2024 | BC | SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve Quarterly Financial Results | 01-Aug-2024 | |